Sfoglia per Autore
COP/CHOP regimens as first line chemotherapy in primary cutaneous lymphomas: a clinical follow-up study of 98 patients.
1999-01-01 Fierro MT; Quaglino P; Savoia P; Verrone A; Bernengo MG
Systemic polychemotherapy in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 81 patients treated with COP or CHOP
1998-01-01 M.T. FIERRO; P. QUAGLINO; P. SAVOIA; A. VERRONE; M.G. BERNENGO
'Aleukemic' granulomatous leukemia cutis.
1998-01-01 TOMASINI C ;QUAGLINO P ;NOVELLI M ;FIERRO MT
Caratterizzazione immunoistochimica e citofluorimetrica di una nuova linea di melanoma.
1998-01-01 Salomone B; Osella-Abate S; Fierro MT; Bernengo MG
Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features.
1998-01-01 M.G. BERNENGO; P. QUAGLINO; M. NOVELLI; N. CAPPELLO; G.C. DOVEIL; F. LISA; A. DE MATTEIS; M.T. FIERRO; A. APPINO
CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease.
1997-01-01 P. SAVOIA; FIERRO MT; NOVELLI M; QUAGLINO P; VERRONE A; GEUNA M; BERNENGO MG
Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.
1997-01-01 FIERRO MT; DOVEIL GC; QUAGLINO P; P. SAVOIA; VERRONE A; BERNENGO MG
Fludarabine phosphate in advanced mycosis fungoides Sezary syndrome: A phase II trial
1997-01-01 Bernengo MG; Fierro MT; Quaglino P; Verrone A;
Systemic chemoterapy in the treatment of advanced cutaneous T-cell lymphomas: effectiveness of COP/CHOP and VICOP-B regimens.
1997-01-01 Bernengo MG; Fierro MT; Doveil GC; Quaglino P; Savoia P
Biological prognostic factors in advanced metastatic melanoma patients treated with chemoimmunotheraphy.
1997-01-01 Fierro MT; Quaglino P; Lisa F; Savoia P; Bernengo MG
Effectiveness of COP/CHOP regimens in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 80 patients.
1997-01-01 Bernengo MG; Fierro MT; Quaglino P; Savoia P; Appino A
Effectivness of COP/CHOP regimens in the treatment of primary cutaneous lymphomas: a clinical follow-up study of 80 patients.
1997-01-01 Bernengo MG; Fierro MT; Quaglino P; Savoia P; Appino A
Prognostic factors in Sezary sindrome
1997-01-01 Bernengo MG; Quaglino P; Novelli M; Cappello N; Doveil GC; Lisa F; De Matteis A; Fierro MT; Appino A.
Linfomi CD56 positivi: presentazione di 5 casi.
1996-01-01 Savoia P; Fierro MT; Novelli M; Verrone A; Quaglino P; Tomasini C
Low-dose integrated chemoimmuno-hormonotherapy with cisplatin, subcutaneous interleukin-2, alpha-interferon and tamoxifen for advanced metastatic melanoma--a pilot study.
1996-01-01 BERNENGO MG; DOVEIL GC; BERTERO M; QUAGLINO P; FIERRO MT; P. SAVOIA; APPINO A; COLONNA S
Multivariate analysis of prognostic factors in 58 Sézary syndrome patients
1996-01-01 Bernengo MG; Quaglino P; Novelli M; Cappello N; Fierro MT; Appino A.
Skin infiltrating lymphocyte flow-cytometric immunophenotyping: automated mechanical biopsy disaggregation and CD45 gating.
1996-01-01 Novelli M; Fierro MT; Lisa F; De Matteis A; Quaglino P; Savoia P; Verrone A; Cambieri I; Bernengo MG
Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases.
1996-01-01 NOVELLI M ;SAVOIA P ;FIERRO MT ;VERRONE A ;QUAGLINO P ;BERNENGO MG
Metastasi tardive di melanoma: presentazione di 15 casi ed individuazione di possibili fattori di rischio associati.
1996-01-01 Quaglino P; Verrone A; Fierro MT; Appino A; Savoia P; Doveil GC; Bernengo MG
Associazione di ciclofosfamide, vincristina e prednisone (COP) nel trattamento dei linfomi cutanei: 20 anni di follow-up.
1996-01-01 Fierro MT; Verrone A; Savoia P; Quaglino P; Doveil GC; Bernengo MG
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile